Search research articles
Contact Us
Filters
Showing results (91-100 of 291) with videos related to
Page
of 30
Sort By:
JCI Insight
|
December 20, 2019
Multipanel mass cytometry reveals anti-PD-1 therapy-mediated B and T cell compartment remodeling in tumor-draining lymph nodes
Won Jin Ho, Mark Yarchoan, Soren Charmsaz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 12, 2003
Identification and characterization of the immunodominant rat HER-2/neu MHC class I epitope presented by spontaneous mammary tumors from HER-2/neu-transgenic mice
Anne M Ercolini, Jean-Pascal H Machiels, Yi Cheng Chen, et al.
Cancer Immunology Research
|
August 14, 2021
Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy
Lauren Dennison, Amanda Ruggieri, Aditya Mohan, et al.
Plos One
|
February 24, 2012
Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cells
Vivian L Weiss, Timothy H Lee, Hong Song, et al.
Journal for Immunotherapy of Cancer
|
November 15, 2018
Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer
May Tun Saung, Stephen Muth, Ding Ding, et al.
Vaccine
|
August 7, 2007
Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice
Timothy P Moran, Joseph E Burgents, Brian Long, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2020
Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis
Arsen Osipov, Su Jin Lim, Aleksandra Popovic, et al.
ACS Applied Materials & Interfaces
|
February 2, 2019
Human Cancer Cell Membrane-Coated Biomimetic Nanoparticles Reduce Fibroblast-Mediated Invasion and Metastasis and Induce T-Cells
Jiefu Jin, Balaji Krishnamachary, James D Barnett, et al.
Genome Medicine
|
August 11, 2021
Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors
Emily F Davis-Marcisak, Allison A Fitzgerald, Michael D Kessler, et al.
Journal of Visualized Experiments : Jove
|
January 19, 2013
Immunohistochemical staining of B7-H1 (PD-L1) on paraffin-embedded slides of pancreatic adenocarcinoma tissue
Elaine Bigelow, Katherine M Bever, Haiying Xu, et al.
Page
of 30
Search research articles
Search
Showing results (91-100 of 291) with videos related to
Sort By:
Page
of 30
JCI Insight
|
December 20, 2019
Multipanel mass cytometry reveals anti-PD-1 therapy-mediated B and T cell compartment remodeling in tumor-draining lymph nodes
Won Jin Ho, Mark Yarchoan, Soren Charmsaz, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 12, 2003
Identification and characterization of the immunodominant rat HER-2/neu MHC class I epitope presented by spontaneous mammary tumors from HER-2/neu-transgenic mice
Anne M Ercolini, Jean-Pascal H Machiels, Yi Cheng Chen, et al.
Cancer Immunology Research
|
August 14, 2021
Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy
Lauren Dennison, Amanda Ruggieri, Aditya Mohan, et al.
Plos One
|
February 24, 2012
Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cells
Vivian L Weiss, Timothy H Lee, Hong Song, et al.
Journal for Immunotherapy of Cancer
|
November 15, 2018
Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer
May Tun Saung, Stephen Muth, Ding Ding, et al.
Vaccine
|
August 7, 2007
Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice
Timothy P Moran, Joseph E Burgents, Brian Long, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 27, 2020
Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis
Arsen Osipov, Su Jin Lim, Aleksandra Popovic, et al.
ACS Applied Materials & Interfaces
|
February 2, 2019
Human Cancer Cell Membrane-Coated Biomimetic Nanoparticles Reduce Fibroblast-Mediated Invasion and Metastasis and Induce T-Cells
Jiefu Jin, Balaji Krishnamachary, James D Barnett, et al.
Genome Medicine
|
August 11, 2021
Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors
Emily F Davis-Marcisak, Allison A Fitzgerald, Michael D Kessler, et al.
Journal of Visualized Experiments : Jove
|
January 19, 2013
Immunohistochemical staining of B7-H1 (PD-L1) on paraffin-embedded slides of pancreatic adenocarcinoma tissue
Elaine Bigelow, Katherine M Bever, Haiying Xu, et al.
Page
of 30